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Abstract
The clinical confirmation of the relationship between uterine leiomyoma and female infertility is of interest to scholars. 
The aim of our research was to study obstetric history and the level of sex hormones in women of reproductive age with 
leiomyoma. 
Materials and methods. The main group consisted of 90 women of reproductive age with uterine leiomyoma, the control 
group – 45 healthy women. Gynaecological and obstetric history, hormone content in peripheral blood and pelvic vessels (estradiol, 
progesterone) were analysed. Statistical processing of clinical material was performed using Microsoft Excel, Statistica 7.0, and Statisti- 
ca 8.0 for Windows. 
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Results. The frequency of infertility in the surveyed women with LM was 18.9 %. One in three patients in the main group 
(33.3 %) did not give birth, which was statistically different from the healthy women group. In this case, 25.6 % of women in the main 
group did not use any methods of contraception. It was found that 51.11 % of patients with LM had threatened miscarriage in their 
history, 37.5 % – complicated delivery. Pathological changes in the concentrations of estradiol and progesterone in the preferential 
blood and blood vessels of women with fibroids have been identified. We have found that the content of sex hormones in the local 
bloodstream has a reliable relationship with the location of the myomatous node. 
Conclusion. The obtained results may indicate that leiomyoma contributes to the reduction of fertility. This is evidenced by 
the fact that women with LM are more likely to have the risk of miscarriage, complicated delivery and delivery by caesarean section, 
including complicated one. The findings have made a significant contribution to the further development of effective strategies for the 
prevention and treatment of infertility in women with fibrotic uterine lesions.
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1. Introduction
Uterine leiomyoma (fibroids, fibroma) is a tumour of smooth muscle cells, which is the 
most common gynaecologic oncologic benign disease among women of reproductive age [1, 2]. 
This pathology is often identified in the diagnostic search in infertile couples [3, 4]. Fibroids are 
hormone-dependent tumours and it has been proven that estrogens contribute to their growth: 
local estrogen concentrations at myomatic nodes are higher than in surrounding myometrium, pos-
sibly due to a higher aromatase concentration [5, 6]. In this case, hormonal sensitivity is found 
more in the submucosal than subserous fibroids [7]. The submucosal form of the pathology dis-
cussed adversely affects the rate of implantation, the clinical course of pregnancy, its duration and 
outcome [1]. Fibroids can cause infertility through obstruction of the fallopian tubes, impaired 
migration of sperm and gamete transport, implantation of blastocysts through venous ectasia and 
endometrial atrophy near myoma, as well as increased expression of angiogenetic factors [4, 5].
The clinical confirmation of the relationship between leiomyoma and female infertility is of 
interest to scholars. Therefore, the aim of our research was to study obstetric history and the level 
of sex hormones in women of reproductive age with leiomyoma.
2. Materials and methods
At the Centre for Minimally Invasive Surgery of the State Scientific Institution “Scientific 
and Practical Centre for Preventive and Clinical Medicine” of the Government Department for 
Management of Affairs and the Academic Medical Centre 135 women of reproductive age were 
surveyed during October 2014 – November 2019. The studies were conducted solely with the writ-
ten consent of participating women. The written consent to participate in the research described in 
detail all the foreseeable health risks and the techniques used in our study. A retrospective and pro-
spective analysis of the case histories of 90 patients (mean age 31.2±1.4 years) of patients with leio-
myoma at different periods of pregnancy before and after organ-saving surgery from 0 to 5 years 
was conducted, which subsequently constituted the main study group – I. Exclusion criteria were 
age of patients over 36 years, disease duration over 5 years, diffuse variant of uterine leiomyoma, 
severe endocrine and autoimmune diseases, type II submucosal nodes. The control group consisted 
of 45 healthy women (mean age 32.7±1.9 years). The analysis of family, somatic, gynaecological 
and obstetric history with detailed study of socio-economic status and working conditions of pa-
tients, general somatic examination, bimanual gynaecological examination, examination of the 
uterine cervix in the speculum, colposcopic examination data, the content of hormones in the pe-
ripheral blood and pelvic vessels (estradiol, progesterone) was conducted. Serum hormone content 
was determined before and after surgery, as well as during surgery applying radioimmunoassay 
technique using standard kits of reagents produced by Immunotech (Czech Republic). Surgical 
intervention in patients of the reproductive age of the main group was performed in the form of 
hysteroscopic examination applying the standard technique. 
The study was based on the ethical principles of scientific research with the inclusion of 
people (Helsinki Declaration) and the provisions of the recommendations of GCP (good clinical 
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practice). The study design was approved by the Centre for Minimally Invasive Surgery of the 
State Scientific Institution’s Ethics Commission “Scientific and Practical Centre for Preventive and 
Clinical Medicine” of the Government Department for Management of Affairs and the Academic 
Medical Centre (protocol No. 24, 17.09.2014).
Statistical processing of clinical material was performed using Microsoft Excel, Statistica 7.0, 
and Statistica 8.0 for Windows. The sample parameters given in the tables were denoted as follows: 
M is the mean, n is the size of the analysed subgroup, p is the obtained significance level. The crit-
ical significance level was assumed to be<0.05 according to χcriteria.
3. Results
In our cohort of surveyed women with leiomyomas (n=90), the incidence of infertility was 
18.9 % (n=17). One in three patients in the main group (33.3 %) did not give birth, which was sta-
tistically different from the healthy women group (16.65 %, p=0.0002). At the same time, 25.6 % of 
women in the main group did not use any methods of contraception.
The analysis of contraceptive methods allowed revealing a slightly higher rate of the use 
of intrauterine devices 24.5 % (n=22) and lower rate of the use of barrier methods 10.0 % (n=9) 
in women with LM relative to healthy control group women (Fig. 1). In the course of the study 
it was found that among the surveyed contingent there was a low level of oral contraceptive use 
13.33 % (n=12) in Group I compared to control group 30.0 % (n=30), which can inhibit the de-
velopment of fibroids (Fig. 1). It is noted that only women with the discussed pathology used the 
hormone-releasing intrauterine system – Mirena. 
In the course of the study of obstetric history in women, with the presence of fibroids, there 
was a higher proportion of women who had a history of complicated childbirth (37.5 %), caesarean 
section (45.3 %) against the indicators of the control group (3.3 % and 17.4 %, respectively, p=0.017). 
At the same time, in Group 1 there was a higher percentage of caesarean sections with complications – 
in 3 cases (4.7 %), and in СG such cases did not occur (Table 1). There were 46 (51.11 %) women of 
Group I, compared to 6 (26.1 %) women of CG, who had interruptions of pregnancy in their medical 
history. As regards abortions in medical history, in Group I the number of women who had abortions 
49 (54.4 %) was significantly higher than in the control group – 8 (26.6 %). At the same time, in 
Group I there was a more specific proportion of women who had two abortions – 15 (30.6 %) cases, 
versus 2 (25 %) in CG. The proportion of patients with three abortions in medical history significantly 
prevailed in Group I – 9 (18.4 %) women (Table 1). No such women were found in CG.
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Characteristics of reproductive function in surveyed women 
Deliveries 
Group І  
(women with fibroids)  
n=90
Control group  




abs. % abs. %
0 30 33.3 5 16.6
19.1 
0.0002
1 51 56.6 14 46.6
2 4 4.4 10 33.3
3 and more 5 5.5 1 3.3
Course of delivery (n=74) (n=23)
Physiological delivery 45 54.7 19 32.6
5.6 
0.017
including complicated 24 37.5 3 13.0
Сaesarean section 19 45.3 4 17.4
including complicated case 3 4.7 0 0
Threatened miscarriage 46 51.11 6 26.1 5.0 0.025
Abortions in medical history, including 49 54.4 8 26.6 4.4 0.034
1 25 51.0 6 75.0
1.1 
0.5762 15 30.6 2 25.0
3 and more 9 18.4 0 0
In women with the pathology under discussion, estradiol levels in the blood tended to in-
crease continuously throughout the menstrual cycle. On day 5–7, its level exceeded the level of 
estradiol in women of CG almost twice (Fig. 2). However, on day 12–14 of the cycle, its secretion 
level was almost 1.5 times lower (0.49±0.3 nmol/ml) than the estradiol secretion level in the control 
group (0.62±0.03 nmol/ml). On day 21–24, its level was almost no different from that of healthy 
women (Fig. 2).
Fig. 2. The level of estradiol (nmol/ml) in the preferential blood of the women of both groups
The level of progesterone in women with fibroids on day 5–7 of the menstrual cycle was 
higher compared to the CG values – 3.72±0.02 nmol/ml against 2.11±0.77 nmol/ml (Fig. 3). On day 
12–14 of the cycle, its level increased to 6.08±0.43 nmol/ml in contrast to the control group. On day 
21–24 of the menstrual cycle, the ratio of progesterone levels in Group I and CG differed almost 
twice (Fig. 3).
We have found that the content of sex hormones in the local bloodstream has a reliable 
relationship with the location of the myomatous node. According to our data, hyperostrogenemia 
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progesterone content, which corresponds to the peripheral indicators of control (Table 2). In addi-
tion to the above, local progesteronemia was observed in the anterior and posterior uterine walls.
Fig. 3. Progesterone level (nmol/ml) in the preferential blood of the women in both groups
Table 2
Indicators of local hormonal homeostasis in surveyed women of reproductive age (M)
Indicators of 
local blood flow
Localization of blood sampling during myomectomy
Groups
Peripheral blood flow  
indicators
Uterine fundus Anterior and posterior uterine walls Isthmus of uterus main control
E2 nmol/l 0.7100.026*,** 0.3450.023* 0.2980.005 *,** 0.5340.023 0.3100.026
P nmol/l 4.600.08** 9.630.05*,** 4.140.03** 4.630.05 2.00.08
Note: statistically significant difference (p<0.05):* – between local indicators and peripheral ones in the main group; ** – between 
local indicators of the main group and peripheral ones of the control group; E2 – estrogen; P – progesterone.
4. Discussion
The literature data on the incidence of leiomyoma among infertile women are controversial. 
According to Dueholm M et al. [7], from 5 % to 10 % of infertile women have 1 or more fibroids. 
However, when all other causes of infertility are ruled out, fibroids are found only in 1–2 % of 
women [8]. Both infertility and age are associated with fibroids and can therefore confuse doctors 
trying to clarify the link between fibroids and infertility [9]. No studies have been conducted to 
date to indicate a direct cause-and-effect relationship between fibroids and infertility. In our cohort 
of surveyed women with leiomyomas, the incidence of infertility was 18.9 %.
Many hypotheses have been created to explain how fibroids can cause infertility. Studies 
of the blood supply to the vessels of uterus have shown that blood flow to the uterine fibroids 
is less than to the adjacent myometrium [1]. Endometrial inflammation and changed local hor-
monal environment, which was clinically proven in our study, may interfere with embryo im-
plantation. Women with LM were characterized by the absence of ovulatory peak in the analysis 
of hormone secretion in the dynamics of the menstrual cycle, unlike CG healthy women. The 
level of progesterone tended to increase, but in the phase of the maximum hormonal activity of 
the yellow body, its level was insufficient for an adequate luteal phase. Relative hyperostrogeny 
was observed, which was not balanced by adequate progesterone interaction, which could im-
pede the normal course of ovulation, prolonged endometrial proliferation phase, and impaired 
its complete secretory transformation. Thus, the dynamics of continuous synchronous growth of 
estradiol and progesterone throughout the menstrual cycle were traced, which made it impos-
sible for them to have a dominant effect for the formation of a full two-phase menstrual cycle. 
It is proved that the LM on the background of almost normal concentrations of hormones in the 
general bloodstream is characterized by significant disturbances of local hormonal homeostasis 
in the form of relative hyperostrogeny against the background of a decrease in the concentration 
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the arterial and in the venous vessels of the uterus [10, 11]. This is confirmed by our findings that 
the content of sex hormones in the local bloodstream has a reliable relationship with the location 
of the myomatous node.
The ability of myoma to change uterine contractility is described, which may interfere with 
the interaction of sperm and ova or embryo migration [1, 12]. Large intramural fibroids interfere 
with the growth of the pregnant uterus and lead to asymmetric deformations with an increase in the 
contractility of healthy muscles [13]. In our cohort of patients, intramural fibroids and their location 
were most often on the anterior and posterior walls, and sometimes in the fundus in 22 % of the 
surveyed. Intramuscular fibroids can limit the success of in vitro fertilization [4]. During preg-
nancy, a partially significant increase in growth is observed in about 25 % of myomas, especially 
in the first trimester [4]. Pregnancy complications include early and late miscarriages, premature 
birth and rupture of the fetal membranes, chorio/endometritis, placental abruption, and postpartum 
haemorrhage/atony [13, 14].
Several authors have found that fibroids, regardless of their location, significantly reduce 
both implantation and clinical pregnancy [15, 16]. The result of pregnancy is associated with the 
location of fibroids [17, 18]. Subserous fibroma does not affect fertility; all systemic reviews and 
meta-analyses agreed on this. However, Pritts E.A. et al. [9] proved the negative effect of submuco-
sal fibroids (fibroids with endometrial lesions) on implantation rate, clinical course of pregnancy, 
and cases of miscarriages. In our cohort of patients with myomas, cases of threatened miscarriage, 
complicated delivery and delivery by caesarean section, including complications in comparison 
with the data of healthy women, are more often recorded in the in medical history. In this case, 
67 % of the surveyed had subserous localization of nodes.
De Vivo et al. [19] found that 71.4 % of myomas increased during the first and second 
trimesters, while 66.6 % increased between the second and third trimesters, which significantly 
increased the number of pregnancy complications. During pregnancy, myomas can grow rapidly, 
causing severe pain. However, Laughlin S et al. [20] documented fibrosis regression after child-
birth in 72 % of women, with a 50 % decrease in fibroid volume between gestational onset and 
3–6 months after delivery. Women who underwent miscarriage or adminestered progestins after 
childbirth underwent less regression of fibroids, but this difference was not found in women who 
underwent caesarean section, used other hormonal contraceptives, or breast-fed [20]. We found 
a somewhat low level (13.33 %) of oral contraceptive use in patients with leiomyomas. However, 
a slightly higher rate of the use of intrauterine devices in women with fibroids relative to healthy 
control group women may indicate that prolonged use of intrauterine contraceptives may play a 
large role in the emergence of LM in women of fertile age. The high proportion of women who did 
not use barrier means and did not use contraception at all among women in Group I may be a factor 
of risk of increasing the incidence of unwanted pregnancies and artificial abortions, which may 
contribute to the development of uterine tumours.
Study limitations. In our study, infertility level after leyomioma’s surgical treatment was 
not evaluated.
Perspective of further research. To investigate woman fertility level after leyomioma’s 
surgical treatment.
5. Conclusion
The obtained results may indicate that leiomyoma contributes to the reduction of fertility. 
This is evidenced by the fact that women with LM are more likely to have the risk of miscarriage, 
complicated delivery and delivery by caesarean section, including complicated one. This is due to 
endometrial functional failure, deformation of the uterine cavity, impaired contractility and shift of 
steroid hormone balance towards estrogens, including in the local uterine blood flow. The findings 
have made a significant contribution to the further development of effective strategies for the pre-
vention and treatment of infertility in women with fibrotic uterine lesions.
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